Lymphoma Cancer | Tumor

Survivor Offers 5 Tips on Becoming Your Own Advocate

August 3rd 2021, 3:00pm

Article

Nina Luker, a healthy 25 year old, felt invincible. But she says that "naïve perspective was disrupted in a matter of hours."

Pregnant Women With Previous or Current Cancer Diagnoses May Experience More Complications During Delivery

August 2nd 2021, 9:00pm

Article

Pregnant women who had cancer previously or currently have cancer were more likely to experience comorbidities and in-hospital complications, depending on cancer type.

Patients With Blood Cancer Less Likely to Produce COVID-19 Antibodies After Vaccination

July 26th 2021, 1:00pm

Article

About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.

90-Year-Old Will Walk 3,600 Miles for Children With Cancer, KISS and Cinderella Keyboardist Dies From Cancer and More

July 23rd 2021, 3:00pm

Article

From a 90-year-old man’s 3,600-mile walk to raise money for children with cancer to the death of KISS and Cinderella keyboardist Gary Corbett, here’s what’s happening in the cancer landscape this week.

FDA Approval of Rylaze ‘Fulfills an Unmet Need’ for Group of Patients With Leukemia and Lymphoma

July 21st 2021, 1:00pm

Article

The FDA approval of Rylaze provides certain patients with leukemia and lymphoma with an on-demand treatment option since the only other approved therapy is currently undergoing a shortage.

Combination Therapy May Provide New Treatment Option for Patients with Lymphoma

June 23rd 2021, 9:00pm

Video

Monjuvi and Revlimid attained extended remission and improved survival in patients with relapsed or refractory diffuse large B-cell lymphoma.

Immunotherapy Options Around the Bend

June 18th 2021, 1:00pm

Article

One expert tells patients to ‘hang tight’ as immunotherapy options are getting better each year.

Yescarta Associated With Better Outcomes Than Other Available Treatments for Relapsed/Refractory Follicular Lymphoma

June 14th 2021, 6:00pm

Article

These findings, according to one of the study’s authors, demonstrate that Yescarta addresses an important unmet medical need for patients with relapsed/refractory follicular lymphoma.

Learning to Live with an Incurable, Inoperable Cancer

June 10th 2021, 3:00pm

Podcast

In this episode of the “CURE® Talks Cancer” podcast, author Steve Kelley shares both the painful and positive moments of his journey with a rare cancer.

Novel Triplet Combination Shows ‘Notable Efficacy in a Challenging to Treat’ Population of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

June 6th 2021, 2:00pm

Article

Treatment with the combination of Polivy, rituximab and lenalidomide safely conferred responses in patients with relapsed/refractory diffuse large B-cell lymphoma, with most patients still in remission at the study’s cutoff date.